What is a reasonable starting dose for NPH (Neutral Protamine Hagedorn) insulin in a patient previously on 70/30 (pre-mixed insulin) 33 units who now has hyperglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting from 70/30 to NPH Insulin in Hospitalized Patients with Hyperglycemia

Recommended Starting NPH Dose

Start with 26 units of NPH insulin given as a split dose: 18 units in the morning and 8 units at bedtime (approximately 80% of the previous 70/30 total daily dose, distributed as 2/3 morning and 1/3 evening). 1

Rationale for Dose Conversion

  • When converting from premixed 70/30 insulin to NPH, the American Diabetes Association recommends using 80% of the current total daily dose to reduce hypoglycemia risk during the transition 1

  • The 70/30 insulin contains 70% intermediate-acting (NPH-like) and 30% rapid-acting components, so the patient was receiving approximately 23 units of basal coverage from their previous 33-unit dose 1

  • Splitting the NPH dose into twice-daily administration (2/3 morning, 1/3 evening) provides better 24-hour glucose coverage than once-daily dosing, particularly for patients with persistent hyperglycemia in the 200s mg/dL range 1

Additional Prandial Coverage Needed

  • Since the patient is now hospitalized and eating regular meals, add rapid-acting insulin at mealtimes starting with 4 units before each meal or 10% of the basal dose 1

  • This prandial insulin replaces the rapid-acting component that was previously provided by the 70/30 formulation (approximately 10 units total daily) 1

  • For the largest meal or meal with greatest postprandial glucose excursion, consider starting with the full prandial dose first, then expanding to other meals if needed 1

Titration Strategy

  • Increase NPH by 2 units every 2-3 days if fasting glucose remains >180 mg/dL, targeting inpatient goals of <110 mg/dL fasting and 110-180 mg/dL throughout the day 1, 2

  • If hypoglycemia occurs (glucose <70 mg/dL), reduce the corresponding NPH dose by 10-20% 1

  • Adjust prandial insulin by 1-2 units or 10-15% twice weekly based on pre-meal and 2-hour postprandial glucose values 1

Important Clinical Considerations

  • Monitor glucose every 4-6 hours initially to assess adequacy of the new regimen and identify patterns of hyper- or hypoglycemia 1, 2

  • The patient's persistent hyperglycemia in the 200s suggests they were undertreated on their home regimen, so aggressive titration upward may be necessary after the initial conservative conversion 1

  • If the patient has renal or hepatic impairment, is elderly, frail, or has other conditions increasing hypoglycemia risk, consider starting with an even lower dose (reduce by an additional 10-20%) 1

  • For patients with marked obesity, active infection, or open wounds, the starting dose may need to be higher (add 0.2 units/kg to the basal component) 2

Common Pitfalls to Avoid

  • Do not use a 1:1 conversion from 70/30 to NPH—this will provide excessive basal insulin and increase hypoglycemia risk since 70/30 contains both basal and prandial components 1

  • Avoid giving all NPH at bedtime only, as this will not adequately cover daytime hyperglycemia in a patient with glucose readings in the 200s 1

  • Ensure the patient continues to receive basal insulin even if made NPO—reduce the dose but do not discontinue, especially if there is any possibility of type 1 diabetes 1

  • Watch for overbasalization (basal dose >0.5 units/kg/day, elevated bedtime-to-morning differential, or frequent hypoglycemia), which signals need for more prandial and less basal insulin 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Insulin management of diabetic patients on general medical and surgical floors.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.